GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ranbaxy Laboratories Ltd (FRA:RLYG) » Definitions » Price-to-Tangible-Book

Ranbaxy Laboratories (FRA:RLYG) Price-to-Tangible-Book : 11.86 (As of May. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Ranbaxy Laboratories Price-to-Tangible-Book?

As of today (2024-05-07), Ranbaxy Laboratories's share price is €8.10. Ranbaxy Laboratories's Tangible Book per Share of Sep. 2014 for the quarter that ended in Sep. 2014 was €0.68. Hence, Ranbaxy Laboratories's Price to Tangible Book Ratio of today is 11.86.

The historical rank and industry rank for Ranbaxy Laboratories's Price-to-Tangible-Book or its related term are showing as below:

FRA:RLYG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.3   Med: 11.26   Max: 20.95
Current: 15.28

During the past 8 years, Ranbaxy Laboratories's highest Price to Tangible Book Ratio was 20.95. The lowest was 5.30. And the median was 11.26.

FRA:RLYG's Price-to-Tangible-Book is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.42 vs FRA:RLYG: 15.28

A closely related ratio is called PB Ratio. As of today, Ranbaxy Laboratories's share price is €8.10. Ranbaxy Laboratories's Book Value per Sharefor the quarter that ended in Sep. 2014 was €1.15. Hence, Ranbaxy Laboratories's P/B Ratio of today is 7.04.


Ranbaxy Laboratories Price-to-Tangible-Book Historical Data

The historical data trend for Ranbaxy Laboratories's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ranbaxy Laboratories Price-to-Tangible-Book Chart

Ranbaxy Laboratories Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Price-to-Tangible-Book
Get a 7-Day Free Trial 25.35 2.30 11.29 7.60 21.28

Ranbaxy Laboratories Quarterly Data
Dec11 Dec12 Jun13 Sep14
Price-to-Tangible-Book 21.28 10.94 5.46 10.98

Competitive Comparison of Ranbaxy Laboratories's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Ranbaxy Laboratories's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ranbaxy Laboratories's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ranbaxy Laboratories's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ranbaxy Laboratories's Price-to-Tangible-Book falls into.



Ranbaxy Laboratories Price-to-Tangible-Book Calculation

Ranbaxy Laboratories's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2014 )
=8.10/0.683
=11.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Ranbaxy Laboratories Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ranbaxy Laboratories's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Ranbaxy Laboratories (FRA:RLYG) Business Description

Traded in Other Exchanges
N/A
Address
Ranbaxy Laboratories Ltd., is an integrated international pharmaceuticals company. It markets, produces and distributes pharmaceuticals products.

Ranbaxy Laboratories (FRA:RLYG) Headlines

No Headlines